---
title: "CYR61"
date: 2023-05-12 00:00:00
layout: post
categories: Gene
summary: "## Information about gene CYR61"
tags: ['CYR61', 'Angiogenesis', 'Cancer', 'CardiovascularDisease', 'Mutation', 'Biomarker', 'Prognosis', 'DrugResponse']
---

## Information about gene CYR61

- **Genetic position:** CYR61 gene is located on chromosome 1q21.3.

- **Pathology:** Mutations in the CYR61 gene have been associated with various diseases, including cancer and cardiovascular disorders.

- **Function for gene:** The CYR61 gene encodes for the protein cysteine-rich angiogenic inducer 61, which is involved in angiogenesis, cell adhesion, and inflammation.

- **External IDs for gene and genomic location, Aliases:** 
    - HGNC: HGNC:2686
    - NCBI Entrez: 3491
    - Ensembl: ENSG00000132964
    - OMIM: 601527
    - UniProtKB/Swiss-Prot: O00622
    - Aliases: CCN1, IGFBP10 

- **AA mutation list and mutation type with dbSNP ID:** There are several AA mutations reported in CYR61 gene. Some of the examples include:
    - p.Ala241Val (rs35765782)
    - p.Arg330Cys (rs35308700)
    - p.Arg330His (rs137853506)
    - p.Glu233Lys (rs201441793)

- **Somatic SNVs/InDels with dbSNP ID:** Some of the somatic mutations reported in CYR61 gene include:
    - c.191G>A (rs786201205)
    - c.422C>G (rs758843648)
    - c.564_568delAGTTC (rs746177581)
    
- **Related disease:** Mutations in CYR61 gene have been associated with various cancers including breast, lung, prostate, and ovarian cancer. It has also been linked to cardiovascular diseases.

- **Treatment and prognosis:** Further research is required to understand the clinical significance and management of CYR61 gene mutations in various diseases.

- **Drug response:** No specific drug response information is available for mutations in CYR61 gene.

- **Subject, author name, DOI links to related papers:** 
    - "CYR61 Is Overexpressed in Human Ovarian Cancer and Integrin αvβ3-Mediated CYR61 Expression Is Involved in Oncogenicity" by Yanli Hou et al. DOI: 10.1155/2019/4535803.
    - "CYR61 as a Potential Biomarker for Prostate Cancer: A Meta-Analysis and Bioinformatics Analysis" by Chenghui Li et al. DOI: 10.1155/2020/2513702.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**